Success Metrics

Clinical Success Rate
75.0%

Based on 9 completed trials

Completion Rate
75%(9/12)
Active Trials
3(14%)
Results Posted
22%(2 trials)
Terminated
3(14%)

Phase Distribution

Ph phase_2
3
14%
Ph phase_3
3
14%
Ph phase_1
5
24%
Ph early_phase_1
1
5%
Ph not_applicable
9
43%

Phase Distribution

6

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution21 total trials
Early Phase 1First-in-human
1(4.8%)
Phase 1Safety & dosage
5(23.8%)
Phase 2Efficacy & side effects
3(14.3%)
Phase 3Large-scale testing
3(14.3%)
N/ANon-phased studies
9(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

69.2%

9 of 13 finished

Non-Completion Rate

30.8%

4 ended early

Currently Active

3

trials recruiting

Total Trials

21

all time

Status Distribution
Active(3)
Completed(9)
Terminated(4)
Other(5)

Detailed Status

Completed9
unknown5
Recruiting3
Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
3
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (4.8%)
Phase 15 (23.8%)
Phase 23 (14.3%)
Phase 33 (14.3%)
N/A9 (42.9%)

Trials by Status

recruiting314%
withdrawn15%
unknown524%
completed943%
terminated314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT05030298Phase 1

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

Recruiting
NCT01891318Phase 1

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Recruiting
NCT04612140Not Applicable

STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease

Completed
NCT03398694Not Applicable

Pre-operative Stereotactic Radiosurgery Followed by Resection for Patients With Brain Metastases

Completed
NCT02978404Phase 2

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Completed
NCT00944528Phase 1

Single Dose Partial Breast Radiotherapy

Completed
NCT03697343Phase 3

Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

Recruiting
NCT05081908Not Applicable

Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.

Unknown
NCT02167633Not Applicable

Stereotactic Radiosurgery in Metastatic Spinal Cord Compression

Terminated
NCT02055859Not Applicable

Cyberknife Radiosurgery for Patients With Neurinomas

Unknown
NCT02500888Not Applicable

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

Unknown
NCT01594892Not Applicable

Fractionated Radiosurgery for Painful Spinal Metastases

Completed
NCT01739439Phase 1

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Terminated
NCT01086345Early Phase 1

Radiosurgery Plus Bevacizumab in Glioblastoma

Terminated
NCT00860145Not Applicable

Radiosurgery or Open Surgery for Epilepsy Trial

Completed
NCT00573872Not Applicable

A Phase II Study of Spinal Radiosurgery

Completed
NCT00311597Phase 1

Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors

Completed
NCT01231061Phase 2

Spinal met_radiosurgery/SBRT Study

Completed
NCT01169129Phase 3

Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases

Withdrawn
NCT01301560Phase 3

Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis

Unknown

Drug Details

Intervention Type
RADIATION
Total Trials
21